/
| GEL thousands | 2024¹ | 2025 |
|---|---|---|
| P&L Items | ||
| Revenue | 106,554 | Register |
| Adj. Operating Profit² | 2,415 | Register |
| Adj. EBITDA² | 13,875 | Register |
| Net Income | (4,363) | Register |
| Margins & Profitability Ratios (%) | ||
| Adj. Operating Profit Margin² | 2.3% | Register |
| Adj. EBITDA Margin² | 13.0% | Register |
| Net Income Margin | -4.1% | Register |
| Balance Sheet Items & Leverage | ||
| Total Assets | 261,401 | Register |
| Total Debt³ | 63,378 | Register |
| Total Debt³ / Adj. EBITDA² | 4.57x | Register |
| Total Equity | 163,437 | Register |
| ROAE | -3.0% | Register |
¹ From 11 January 2024 includes the general hospitals of JSC Evex Clinics (19 hospitals and 2 subsidiaries, net assets GEL 41.2m) merged under common control; prior years were not restated.
² Adj. Operating Profit has been adjusted to exclude non-recurring and one-time items. Adj. EBITDA is calculated by adding back D&A expenses to the adjusted operating profit.
³ Total debt includes lease liabilities, where applicable.